3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Lung Neoplasms
4
Glioma
3
Glioblastoma
3
Breast Neoplasms
3
Head and Neck Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Uterine Cervical Neoplasms
1
Sarcoma
1
Rhabdomyosarcoma
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Pancreatic Ductal Adenocarcinoma
1
Osteoradionecrosis
1
Neurotoxicity Syndromes
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Mouth Neoplasms
1
Melanoma
1
Lymphoma, B-Cell
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Hematopoietic and Lymphoid System Neoplasm
1
Ependymoma
1
Cytokine Release Syndrome
1
Craniopharyngioma
1
Colorectal Neoplasms
1
Carcinoma, Hepatocellular
1
Brain Neoplasms
1
Interventions
Pancreaticoduodenectomy
2
titanium silicide
1
tislelizumab
1
sonidegib
1
paricalcitol
1
mitazalimab
1
lenvatinib
1
ivosidenib
1
irinotecan sucrosofate
1
glucoraphanin
1
devimistat
1
Transurethral Resection of Prostate
1
Tissue Banks
1
Specimen Handling
1
Saline Solution
1
S 1 (combination)
1
Ropivacaine
1
Robotic Surgical Procedures
1
Radiomics
1
Positron Emission Tomography Computed Tomography
1
Parturition
1
PEGPH20
1
Oxaliplatin
1
Neoadjuvant Therapy
1
Magnetic Resonance Spectroscopy
1
Losartan
1
Irinotecan
1
Immunotherapy
1
Hydroxychloroquine
1
Glucose
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Pancreatic Ductal Adenocarcinoma
×
Contrast Media
×
Clear all
NCT07324096
2026-03-27
AI-PACED
Mayo Clinic
Phase NA
Recruiting
100 enrolled